close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
News headline image
Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers ASND
Exposures Product Safety
News headline image
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
Tickers QDEL
Exposures Product Safety Tariff
News headline image
Vanda (VNDA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers VNDA
Exposures Financial Product Safety
News headline image
The Unsung Heroes of the Stage: Greg Nelson Goes “Behind the Sound” on the Blue Collar Trade Show Podcast
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
420 with CNW — Deadline Looms for the FDA to Publish Cannabinoids List
Via CannabisNewsWire
Topics Cannabis
Tickers ACB TSX:ACB
Exposures Cannabis Product Safety
420 with CNW — Deadline Looms for the FDA to Publish Cannabinoids List
Via Investor Brand Network
Topics Cannabis
Tickers ACB TSX:ACB
Exposures Cannabis Product Safety
The Evolution of Emergency Preparedness: Why Tactical Trauma Kits Are Replacing Standard First Aid Boxes in 2026
Via AB Newswire
Exposures Product Safety
News headline image
PolyPid (PYPD) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers PYPD
Exposures Financial Product Safety
News headline image
The Compliance Multiplier: How Full Service Logistics Reduces Regulatory Risk Across the Supply Chain
Via GetFeatured
Topics Economy Product Recall Supply Chain
Exposures Legal Product Safety Supply Chain
News headline image
Merck&#39;s Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients ↗
Via Benzinga
Exposures Product Safety
News headline image
Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
Via The Motley Fool
Topics Artificial Intelligence
Tickers CVS JPM LLY NVDA NVO RGNX
Exposures Artificial Intelligence Product Safety
News headline image
Ford Motor Company (F) Deep Dive: Navigating the Hybrid Pivot and the Future of Ford Pro
Via Finterra
Topics Bankruptcy Economy Electric Vehicles
Tickers ARM BYDDY F GM LCID SQ
Exposures Electric Vehicles Financial Interest Rates
News headline image
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
Via Finterra
Topics Artificial Intelligence
Tickers BDX BLK DGX GLW LH
Exposures Artificial Intelligence COVID-19 Product Safety
News headline image
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
Via Finterra
Topics Economy Intellectual Property
Tickers ABBV BLK BMY GSK INCY LLY
Exposures Intellectual Property Interest Rates Product Safety
News headline image
Moderna (MRNA) Deep Dive: Navigating Regulatory Blows and the Pivot to Oncology
Via Finterra
Topics Artificial Intelligence Initial Public Offering Intellectual Property
Tickers ARM BNTX MRNA PFE SQ
Exposures Artificial Intelligence COVID-19 Intellectual Property
News headline image
Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
Tickers BAX BDX BLK JPM MDT RY
Exposures Artificial Intelligence Intellectual Property Legal
News headline image
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
Via Newsfile
Tickers ASX:COH COCH
Exposures Product Safety
News headline image
Veru (VERU) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers VERU
Exposures Financial Product Safety
News headline image
FDA Refuses To Review Moderna&#39;s Influenza Shot Application ↗
Via Benzinga
Exposures Product Safety
News headline image
Nasdaq, S&P 500 Futures Rise Ahead Of Delayed Jobs Data: Why NVDA, WBD, HOOD, MRNA, ASTS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
Tickers ASTS CSCO DIA F HOOD IVZ
Exposures Artificial Intelligence Product Safety US Equities
News headline image
5 Insightful Analyst Questions From Bio-Techne’s Q4 Earnings Call
Via StockStory
Topics Earnings
Tickers TECH
Exposures Financial Product Safety
News headline image
Aloe Products Center Provides Natural Defense with Their Cancer Cure Supplement
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Why Did Moderna Stock Tumble Nearly 10% After Hours Today? ↗
Via Stocktwits
Tickers MRNA NVAX
Exposures Product Safety
News headline image
Exelixis (EXEL) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers EXEL
Exposures Financial Product Safety
News headline image
Stock Market Today, Feb. 10: Ford Holds Steady as Investors Await Q4 Earnings and 2026 Profitability Outlook ↗
Via The Motley Fool
Topics Initial Public Offering Product Recall Stocks
Tickers F GM STLA
Exposures Legal Product Safety Securities Market
News headline image
Moderna Takes It On The Chin After FDA Rejects Its Messenger-RNA-Based Flu Shot ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
&#39;I Know I&#39;m Going to Be Wealthy&#39;: Warren Buffett&#39;s Son Recalls What His Father Said In His 20s ↗
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
News headline image
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Tickers AZN LLY MRK NVO
Exposures Artificial Intelligence Financial Product Safety
News headline image
Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients ↗
Via Benzinga
Exposures Product Safety
News headline image
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
Via Finterra
Topics Economy Intellectual Property
Tickers ACLX AZN BLK BMY GILD GSK
Exposures Intellectual Property Interest Rates Product Safety
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today